[PDF] Top 20 Poster Session 1: Prostate Cancer (1)
Has 10000 "Poster Session 1: Prostate Cancer (1)" found on our website. Below are the top 20 most common "Poster Session 1: Prostate Cancer (1)".
Poster Session 1: Prostate Cancer (1)
... Methods: Participants were consecutively enrolled from March 2012 to April 2015 if they underwent RARP by a single surgeon. The RARP pro- cedure was performed with a standardized transperitoneal technique and the RARP ... See full document
18
Moderated Poster Session 1: Prostate Cancer
... developed prostate cancer and were treat- ed with radical radiation therapy using IMRT technique delivered via Helical Tomotherapy ...the prostate, with or without the proximal seminal vesicles, ... See full document
5
Moderated Poster Session 1: Basic Science
... of prostate tumor or normal prostate tissue from patients with prostate ...cancerous prostate tissue formed normal, hyperplastic, focal PIN like glandular structures, and adenocar- ...human ... See full document
7
Moderated Poster Session 1: Oncology 1
... Regional Prostate Cancer Surgery CoP formed with representatives from five hospitals, 4 of which perform radi- cal prostatectomy ...comprehensive Cancer Assessment Clinic (CAC); regional ... See full document
10
Moderated Poster Session 1: Oncology I
... of prostate cancer has changed over time with the development of PSA screening, the advent of robotic prostatectomy, and the development of ...the prostate specimen has been removed or not at ...with ... See full document
10
Poster Session 1: Prostate (I)
... significant prostate cancers, and ultimately prostate cancer related ...high-grade prostate cancer ...grade prostate cancer (Gleason ≥ ... See full document
10
Poster Session 4: Urologic Malignancies (1)
... Results: 331 patients, among whom 344 surgeries were performed, were included. The pathologic categories were: clear cell (233), chromophobe (15), hereditary leiomyatosis and renal cell cancer (HLRCC) (3), hybrid ... See full document
8
Moderated Poster Session I: Oncology 1
... intravesical 1%-lidocaine) a rigid 20 ...within 1 cm from cancer border in total amount of ...successful cancer eradication with minimal ... See full document
6
Moderated Poster Session III: Oncology 1
... Background: Almost all men who present with advanced prostate cancer (CaP) and some men who fail therapy are treated with androgen depri- vation therapy (ADT). ADT is not curative and CaP recurs as the ... See full document
7
Moderated Poster Session 6: Bladder and Penile Cancer
... from 1/2006 to 12/2008 was conducted to assess association between receipt of NAC and initial post- surgical LOS, American Society of Anesthesiologists (ASA) score, clinical stage, intraoperative parameters and ... See full document
5
Poster Session 3: Basic Science
... Introduction and Objectives: The IGF axis is comprised of two hormone growth factors (IGF-I and IGF-II), two cell surface receptors (IGF-IR and IGF-IIR), six high-affinity binding proteins (IGFBP-1 to -6), and ... See full document
7
Moderated Poster Session 6: Oncology
... Results: Positive bladder cuff was diagnosed in 6 patients (4.2%). Histopathology revealed CIS in 1, T1 in 4 and T2 in1 patient. There was no significant correlation identified between patient age, past history or ... See full document
6
Poster Session 7: Voiding Dysfunction
... large prostate ≥120cc (PV120) or with indwelling catheter for urinar ...the prostate for the treatment of BPH performed at 6 international ...Warfarin. Prostate size ≥120cc subgroup was defined by ... See full document
13
Poster Session 8: Functional Urology
... cryotherapy, prostate therapy or Bacillus Calmette–Guérin (BCG) ...from 1-19. 62% of patients received >1 injection while 36% received ≥3, and 14% received ... See full document
11
Moderated Poster Session I: Oncology
... CoC-accredited cancer programs and geographic ...Comprehensive Cancer Programs (ACAD), cases were more likely to be treated with a RN if they received care at a Community Cancer Program (CCP) (RR ... See full document
6
Poster Session 10: Transplantation
... Group 1 (n=261 transplants), the most common cause of end-stage kidney disease (ESKD) was congenital abnormality of the genitourinary ...Group 1; three cases of post-transplant lymphoproliferative disease ... See full document
5
Moderated Poster Session 8: Kidney Cancer
... Materials and Methods: We searched MEDLINE for all relevant articles published up to July 31, 2008. We included all randomized-controlled trials (RCTs), cohort studies, and case-based studies that were published in ... See full document
5
Poster Session 6: Prostate (II)
... Introduction: Select patients may respond to additional local treatment after experiencing recurrence following primary radiotherapy (RT) for prostate cancer (PCa). Salvage prostatectomy, the standard of ... See full document
15
Poster Session 4: Kidney Cancer
... Methods: The study focused on 1860 patients with cT1a kidney cancer treated with either LTA or EM between 2000 and 2009 in the Surveillance Epidemiology and End Results-Medicare database. Propensity-score match- ... See full document
11
Poster Session 8: Bladder Cancer
... urothelial cancer of the bladder who were treated conservatively at the University Health Network, Toronto from Jan 2002 to June ...bladder cancer were primary ... See full document
8
Related subjects